TransMedics Group, Inc. (TMDX) stock
TMDXNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 14/3029% below fair value
$96.43+2.52 (+2.68%)
Close on Nov 18, 2026Market cap $3.34BP/E 25.0Yield 0.00%
TransMedics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
TransMedics's market cap was $3.19B on Nov 11, 2026, against $5.00B a year earlier. Over the last 5 years it ranged from $440.63M to $5.60B, with a median of $2.58B.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $3.19B | -23.3% |
| 2025 | Dec 31, 2025 | $4.15B | +98.5% |
| 2024 | Dec 31, 2024 | $2.09B | -18.8% |
| 2023 | Dec 29, 2023 | $2.58B | +30.7% |
| 2022 | Dec 30, 2022 | $1.97B | +270.5% |
| 2021 | Dec 31, 2021 | $531.98M | -1.6% |
| 2020 | Dec 31, 2020 | $540.47M | +206.7% |
| 2019 | Dec 31, 2019 | $176.21M | – |
See a number that looks wrong?